IVA
Inventiva S.A.
NASDAQ · Healthcare · Biotechnology · FR
$4.78
−1.24%Institutional positioning
13F filings over the trailing two quarters
New 24Increased 21Reduced 11Sold out 63
| Filer | Action | Shares | Filed |
|---|---|---|---|
| SAMSARA BIOCAPITAL, LLC | Unchanged | 5,194,805 | May 15, 2026 |
| CALIGAN PARTNERS LP | Increased | 4,974,906 | May 15, 2026 |
| PARADIGM BIOCAPITAL ADVISORS LP | Unchanged | 4,000,000 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 2,987,613 | May 15, 2026 |
| Trails Edge Capital Partners, LP | Unchanged | 2,657,997 | May 15, 2026 |
| FRANKLIN RESOURCES INC | Reduced | 2,461,565 | May 13, 2026 |
| SymBiosis Capital Partners, LLC | Reduced | 2,354,000 | May 12, 2026 |
| UBS GROUP AG | Reduced | 2,318,693 | May 5, 2026 |
| ADAR1 CAPITAL MANAGEMENT, LLC | Reduced | 2,174,398 | May 18, 2026 |
| POLAR CAPITAL HOLDINGS PLC | Increased | 2,132,138 | May 15, 2026 |
| ANDERA PARTNERS | Unchanged | 1,818,181 | May 11, 2026 |
| CITADEL ADVISORS LLC | Increased | 1,784,566 | Sep 2, 2026 |
| YU FAN | Unchanged | 1,500,000 | May 18, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | Increased | 1,470,407 | May 15, 2026 |
| NEA MANAGEMENT COMPANY, LLC | Unchanged | 1,462,586 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings